No Data
Halozyme Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/07/2024 0.02% Piper Sandler $48 → $51 Downgrades Overweight → Neutral 06/04/2024 -1.94% HC Wainwright &
Why Braze Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Shares of Braze, Inc. (NASDAQ:BRZE) rose sharply in today's pre-market trading following better-than-expected first-quarter earnings.Braze reported first-quarter revenue of $135.459 million, beating e
Greif Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/07/2024 23.82% B of A Securities $75 → $76 Maintains Neutral 04/18/2024 15.67% Truist Securities → $71
Forget Tesla And Rivian: America's Iconic School Bus Maker Smokes EV, Auto Giants With 117% Stock Surge
Electric vehicle stocks are not exactly having a great year, but one company that makes low-emission school buses has left auto sector heavyweights in the dust by more than doubling its valuation.What
Braze Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/07/2024 30.33% Piper Sandler $66 → $55 Maintains Overweight 06/03/2024 13.74% Scotiabank $58 → $48 Main
Earnings Call Summary | Tilly's(TLYS.US) Q1 2024 Earnings Conference
The following is a summary of the Tilly's, Inc. (TLYS) Q1 2024 Earnings Call Transcript:Financial Performance:Tilly's reported a net loss of $19.6 million or $0.65 per share in Q1 2024.Total net sales
Forever 365 : Good Luck Buddies